GUERF
Price:
$22.25
Market Cap:
$241.99M
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection managemen...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2017-04-03
Stock Exchange
PNK
Ticker
GUERF
According to Guerbet SA’s latest financial reports and current stock price. The company's current ROE is 8.54%. This represents a change of -1432.57% compared to the average of -0.64% of the last 4 quarters.
The mean historical ROE of Guerbet SA over the last ten years is 7.78%. The current 8.54% ROE has changed 9.86% with respect to the historical average. Over the past ten years (40 quarters), GUERF's ROE was at its highest in in the June 2015 quarter at 7.47%. The ROE was at its lowest in in the December 2022 quarter at -11.71%.
Average
7.78%
Median
9.39%
Minimum
-10.83%
Maximum
14.14%
Discovering the peaks and valleys of Guerbet SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.44%
Maximum Annual ROE = 14.14%
Minimum Annual Increase = -234.45%
Minimum Annual ROE = -10.83%
Year | ROE | Change |
---|---|---|
2023 | 6.31% | -158.24% |
2022 | -10.83% | -234.45% |
2021 | 8.06% | 62.44% |
2020 | 4.96% | -48.29% |
2019 | 9.59% | -24.87% |
2018 | 12.77% | -5.50% |
2017 | 13.51% | 46.99% |
2016 | 9.19% | -34.98% |
2015 | 14.14% | 40.18% |
2014 | 10.08% | 17.26% |
The current ROE of Guerbet SA (GUERF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.18%
5-year avg
3.62%
10-year avg
7.78%
Guerbet SA’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guerbet SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Guerbet SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Guerbet SA's ROE?
How is the ROE calculated for Guerbet SA (GUERF)?
What is the highest ROE for Guerbet SA (GUERF)?
What is the 3-year average ROE for Guerbet SA (GUERF)?
What is the 5-year average ROE for Guerbet SA (GUERF)?
How does the current ROE for Guerbet SA (GUERF) compare to its historical average?